Investigation of Antibiotic-Releasing Biodegradable Composite Bone Cements for Treating Experimental Chronic Maxillofacial Bone Infection

IF 3.9 3区 医学 Q2 ENGINEERING, BIOMEDICAL Journal of biomedical materials research. Part A Pub Date : 2024-12-24 DOI:10.1002/jbm.a.37858
Surajit Mistry, Subhasis Roy, Debarati Bhowmick, Shuvojit Mistry, Jui Chakraborty, Rajiv Roy, Indrasri Das
{"title":"Investigation of Antibiotic-Releasing Biodegradable Composite Bone Cements for Treating Experimental Chronic Maxillofacial Bone Infection","authors":"Surajit Mistry,&nbsp;Subhasis Roy,&nbsp;Debarati Bhowmick,&nbsp;Shuvojit Mistry,&nbsp;Jui Chakraborty,&nbsp;Rajiv Roy,&nbsp;Indrasri Das","doi":"10.1002/jbm.a.37858","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Chronic osteomyelitis of the maxillofacial bones (i.e., jaw bones) is a persistent infection that requires effective treatment. Because systemic antibiotics seldom reach necrotic areas to remove bone infection, local antibiotic carriers such as antibiotic-loaded bone cement can be tried. It is critical to assess the biosafety and efficacy of two new antibiotic-loaded biodegradable composite bone cements for treating chronic mandibular osteomyelitis, and their drug eluting efficiency and other relevant aspects prior to clinical trial. The physico-mechanical properties, and drug release capacity of the cements were determined to be suitable for in vivo application. After inducing chronic osteomyelitis with Staphylococcal strains in 30 female rabbit mandibles, bioactive glass composite cement (0.5 g) and biphasic calcium phosphate composite cement (0.5 g) were implanted in 18 defects (nine/test group) for 84 days to compare the therapeutic efficacy with traditional therapy (control, debridement plus antibiotics in nine defects) using microscopic, micrographic, and radiological examination. Antibiotic concentrations in bone (vancomycin: 34.7–53.2 μg/g, tobramycin: 2.1–2.87 μg/g) after 21 days of installation for both cements were sufficient to eradicate pathogens without causing adverse events. In vivo tests suggest that cement groups outperformed (<i>p</i> &lt; 0.05) traditional therapy in terms of infection clearance and osteoconduction. The gross histologic and micrographic scores of biphasic calcium phosphate composite cement (10.33 ± 0.58 and 8.33 ± 1.53, respectively) indicated that the cement barely surpassed (<i>p</i> &gt; 0.05) the other composite cement (12.67 ± 1.53 and 10.0 ± 1.0, respectively). These findings emphasize the potential of antibiotic loaded composite cements as an effective treatment option for chronic maxillofacial osteomyelitis, offering a safer and more efficient alternative to traditional therapy.</p>\n </div>","PeriodicalId":15142,"journal":{"name":"Journal of biomedical materials research. Part A","volume":"113 1","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical materials research. Part A","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jbm.a.37858","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Chronic osteomyelitis of the maxillofacial bones (i.e., jaw bones) is a persistent infection that requires effective treatment. Because systemic antibiotics seldom reach necrotic areas to remove bone infection, local antibiotic carriers such as antibiotic-loaded bone cement can be tried. It is critical to assess the biosafety and efficacy of two new antibiotic-loaded biodegradable composite bone cements for treating chronic mandibular osteomyelitis, and their drug eluting efficiency and other relevant aspects prior to clinical trial. The physico-mechanical properties, and drug release capacity of the cements were determined to be suitable for in vivo application. After inducing chronic osteomyelitis with Staphylococcal strains in 30 female rabbit mandibles, bioactive glass composite cement (0.5 g) and biphasic calcium phosphate composite cement (0.5 g) were implanted in 18 defects (nine/test group) for 84 days to compare the therapeutic efficacy with traditional therapy (control, debridement plus antibiotics in nine defects) using microscopic, micrographic, and radiological examination. Antibiotic concentrations in bone (vancomycin: 34.7–53.2 μg/g, tobramycin: 2.1–2.87 μg/g) after 21 days of installation for both cements were sufficient to eradicate pathogens without causing adverse events. In vivo tests suggest that cement groups outperformed (p < 0.05) traditional therapy in terms of infection clearance and osteoconduction. The gross histologic and micrographic scores of biphasic calcium phosphate composite cement (10.33 ± 0.58 and 8.33 ± 1.53, respectively) indicated that the cement barely surpassed (p > 0.05) the other composite cement (12.67 ± 1.53 and 10.0 ± 1.0, respectively). These findings emphasize the potential of antibiotic loaded composite cements as an effective treatment option for chronic maxillofacial osteomyelitis, offering a safer and more efficient alternative to traditional therapy.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
释放抗生素的可生物降解复合骨水泥治疗实验性慢性颌面骨感染的研究。
颌面骨(即颌骨)慢性骨髓炎是一种需要有效治疗的持续性感染。由于全身抗生素很少到达坏死区域以清除骨感染,因此可以尝试局部抗生素载体,如抗生素负载骨水泥。在临床试验前评估两种新型抗生素负载生物可降解复合骨水泥治疗慢性下颌骨髓炎的生物安全性和有效性,以及药物洗脱效率等相关指标至关重要。水泥的物理力学性能和药物释放能力被确定为适合体内应用。用葡萄球菌菌株诱导兔下颌骨慢性骨髓炎后,将生物活性玻璃复合骨水泥(0.5 g)和双相磷酸钙复合骨水泥(0.5 g)植入18个缺损(试验组9个)84 d,通过显微镜、显微摄影和放射学检查,比较传统治疗方法(对照组、清创+抗生素治疗9个缺损)的疗效。两种骨水泥安装21天后,骨内抗生素浓度(万古霉素:34.7-53.2 μg/g,妥布霉素:2.1-2.87 μg/g)足以根除病原体而不引起不良事件。体内试验结果表明,水泥组比其他复合水泥组(分别为12.67±1.53和10.0±1.0)要好(p 0.05)。这些发现强调了抗生素复合水泥作为慢性颌面骨髓炎的有效治疗选择的潜力,提供了一种比传统治疗更安全、更有效的替代方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of biomedical materials research. Part A
Journal of biomedical materials research. Part A 工程技术-材料科学:生物材料
CiteScore
10.40
自引率
2.00%
发文量
135
审稿时长
3.6 months
期刊介绍: The Journal of Biomedical Materials Research Part A is an international, interdisciplinary, English-language publication of original contributions concerning studies of the preparation, performance, and evaluation of biomaterials; the chemical, physical, toxicological, and mechanical behavior of materials in physiological environments; and the response of blood and tissues to biomaterials. The Journal publishes peer-reviewed articles on all relevant biomaterial topics including the science and technology of alloys,polymers, ceramics, and reprocessed animal and human tissues in surgery,dentistry, artificial organs, and other medical devices. The Journal also publishes articles in interdisciplinary areas such as tissue engineering and controlled release technology where biomaterials play a significant role in the performance of the medical device. The Journal of Biomedical Materials Research is the official journal of the Society for Biomaterials (USA), the Japanese Society for Biomaterials, the Australasian Society for Biomaterials, and the Korean Society for Biomaterials. Articles are welcomed from all scientists. Membership in the Society for Biomaterials is not a prerequisite for submission.
期刊最新文献
Keratin Rich PCL Blended Nano-Microfibrous Sheet as a Bioactive Immunomodulatory ECM Analog Toward Dermal Wound Healing—In Vitro and In Vivo Responses Fabrication of 3D Hemispherical PCL-Based Scaffolds Through Far-Field Electrospinning Method for Their Potential Use as Contact Lenses Measurement and Comparison of Hyaluronic Acid Hydrogel Mechanics Across Length Scales Optimizing Tissue-Engineered Periosteum Biochemical Cues to Hasten Bone Allograft Healing Layer-By-Layer Functionalized Gauze With Designed α-Sheet Peptides Inhibits E. coli and S. aureus Biofilm Formation
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1